| Integrated genomic profiling expands clinical options for patients with cancer N Beaubier, M Bontrager, R Huether, C Igartua, D Lau, R Tell, AM Bobe, ... Nature biotechnology 37 (11), 1351-1360, 2019 | 128 | 2019 |
| A pan-cancer organoid platform for precision medicine BM Larsen, M Kannan, LF Langer, BD Leibowitz, A Bentaieb, A Cancino, ... Cell reports 36 (4), 2021 | 63 | 2021 |
| Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort BD Leibowitz, BV Dougherty, JSK Bell, J Kapilivsky, J Michuda, ... BMC cancer 22 (1), 587, 2022 | 24 | 2022 |
| Real-world evidence of diagnostic testing and treatment patterns in US patients with breast cancer with implications for treatment biomarkers from RNA sequencing data LE Fernandes, CG Epstein, AM Bobe, JSK Bell, MC Stumpe, ME Salazar, ... Clinical Breast Cancer 21 (4), e340-e361, 2021 | 12 | 2021 |
| H&E image-based consensus molecular subtype classification of colorectal cancer using weak labeling. AJ Kruger, L Sha, M Kannan, RP Joshi, BD Leibowitz, R Zhang, AA Khan, ... Journal of Clinical Oncology 38 (15_suppl), e16097-e16097, 2020 | 3 | 2020 |
| Systems and methods for predicting homologous recombination deficiency status of a specimen JSK Bell, C Igartua, B Leibowitz US Patent 11,164,655, 2021 | 2 | 2021 |
| Robust detection of sequencing batch effects in RNA through low dimensional embedding with subtype-matched reference samples J Drews, J Bell, W Munson, S Saini, B Leibowitz, J Michuda, C McCarter, ... Cancer Research 80 (16_Supplement), 5466-5466, 2020 | 2 | 2020 |
| Multimodal prediction of diagnosis for cancers of unknown primary J Michuda, B Leibowitz, S Amar-Farkash, C Bevis, A Breschi, J Kapilivsky, ... Cancer Research 80 (16_Supplement), 5423-5423, 2020 | 2 | 2020 |
| Systems and methods for predicting homologous recombination deficiency status of a specimen JSK Bell, C Igartua, B Leibowitz US Patent App. 17/492,518, 2022 | 1 | 2022 |
| Homologous recombination repair pathway alterations and their relationship t o homologous recombination deficiency in advanced pancreatic cancer patients H Patel, A Barrett, E Mauer, S Kato, BD Leibowitz, AD Singhi, AM Lowy J. Clin. Oncol 40 (4), 2022 | 1 | 2022 |
| An integrative molecular framework to predict homologous recombination deficiency. JSK Bell, A Venkat, J Parsons, C Igartua, BD Leibowitz, R Tell, K White Journal of Clinical Oncology 38 (15_suppl), e15664-e15664, 2020 | 1 | 2020 |
| Methods and systems for detecting alternative splicing in sequencing data A Breschi, JSK Bell, J Drews, B Leibowitz, J Michuda US Patent App. 17/963,969, 2023 | | 2023 |
| Systems and methods for predicting homologous recombination deficiency status of a specimen JSK Bell, C Igartua, B Leibowitz US Patent App. 18/064,652, 2023 | | 2023 |
| Real-world evidence of diagnostic testing and treatment patterns in US breast cancer patients with implications for treatment biomarkers from RNA-sequencing data L Fernandes, C Epstein, JSK Bell, NT Beaubier, G Palmer US Patent 11,367,004, 2022 | | 2022 |
| Interrelation of functional homologous recombination deficiency and hrr pathway alterations in prostate cancer. J Zhu, SM El-Refai, E Mauer, BD Leibowitz, LC Brown, C Grigg, JT Kearns, ... Journal of Clinical Oncology 40 (6_suppl), 151-151, 2022 | | 2022 |
| Abstract SS1-04: Comprehensive genomic and transcriptomic profiling of molecular subtypes reveal ancestral differences in the activity of signaling pathways between patients … M Miyashita, JSK Bell, Y Zheng, T Yoshimatsu, PS Rajagopal, A Woodard, ... Cancer Research 81 (4_Supplement), SS1-04-SS1-04, 2021 | | 2021 |
| Abstract PD7-06: Unstable mutational profile and heterogeneity of residual breast tumor following neoadjuvant therapy from comprehensive genomic and transcriptomic sequencing M Miyashita, M Hattori, Y Zheng, T Yoshimatsu, JSK Bell, PS Rajagopal, ... Cancer Research 81 (4_Supplement), PD7-06-PD7-06, 2021 | | 2021 |
| Unstable mutational profile and heterogeneity of residual breast tumor following neoadjuvant therapy from comprehensive genomic and transcriptomic sequencing M Miyashita, M Hattori, Y Zheng, T Yoshimatsu, JSK Bell, PS Rajagopal, ... CANCER RESEARCH 81 (4), 2021 | | 2021 |
| Comprehensive genomic and transcriptomic profiling of molecular subtypes reveal ancestral differences in the activity of signaling pathways between patients with African and … M Miyashita, JSK Bell, Y Zheng, T Yoshimatsu, PS Rajagopal, A Woodard, ... CANCER RESEARCH 81 (4), 2021 | | 2021 |
| Transcriptome background tissue correction in metastatic cancers using a correlated composition admixture model C McCarter, B Leibowitz, J Michuda, JS Bell, C Igartua, KP White Cancer Research 80 (16_Supplement), 5481-5481, 2020 | | 2020 |
Catherine IgartuaHuman Genetics PhD Student, University of ChicagoVerified email at uchicago.edu
